Periconceptional vitamin A use: how much is teratogenic?
about
Vitamin A supplementation during pregnancy for maternal and newborn outcomesVitamin A supplementation during pregnancy for maternal and newborn outcomesVitamin A supplementation during pregnancy for maternal and newborn outcomesNutrient plasma levels achieved during treatment that reduces noise-induced hearing loss.Clinical teratology: identifying teratogenic risks in humans.Exposure to retinyl esters, retinol, and retinoic acids in non-pregnant women following increasing single and repeated oral doses of vitamin A.Spatial heterogeneity of haemoglobin concentration in preschool-age children in sub-Saharan AfricaPersistent behavioral effects following early life exposure to retinoic acid or valproic acid in zebrafish.Monitoring maternal Beta carotene and retinol consumption may decrease the incidence of neurodevelopmental disorders in offspring.Role of micronutrients in the periconceptional period.Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN): could retinoids play a causative role?Retinoid teratogenicity in the macaque: verification of dosing regimen.Effect of vitamin A and beta carotene supplementation on women's healthDietary vitamin A intake below the recommended daily intake during pregnancy and the risk of congenital diaphragmatic hernia in the offspring.Validity of protein, retinol, folic acid and n-3 fatty acid intakes estimated from the food-frequency questionnaire used in the Danish National Birth Cohort.Role of Fat-Soluble Vitamins A and D in the Pathogenesis of Influenza: A New Perspective
P2860
Q24186343-F8994261-1372-4215-9764-A336DD28DC35Q24235629-2ECA5110-07B7-48CF-95D5-77B518799FB6Q24236618-3287DF3B-C088-4719-B064-B6AE01AB7F39Q30466285-D400D38B-EF7A-4074-B63E-18FADD1A29D4Q33832749-5595623C-F09D-48F4-AD33-391D249005BBQ34650788-AFE3C6FD-89A0-4BB2-A1C4-1EAFFAA9F6F4Q34997628-03AB6E24-0501-4155-912F-16742D8A336FQ36578721-3B11007D-6090-4068-BB21-D3B29FB38EBBQ37462997-EB62767A-30D6-4C3F-8B8F-43F5236D2443Q37536492-63507C91-FB6C-44AB-B6F1-B35AB7B47628Q38314486-CBDC28B6-88DA-4B56-9514-61F0D1EF27B2Q41645947-A2284F88-06A0-4A92-A351-5689AB1D4756Q42760932-FA745F18-AC6C-42F0-8458-D370266A031BQ44799614-4931E6F9-C6AD-4AA8-AF4E-D97B972093DBQ50544182-8A1AA780-5D2B-496F-80F3-816A79534093Q58242557-2548E019-D6D7-4835-A524-D3CB920E5433
P2860
Periconceptional vitamin A use: how much is teratogenic?
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Periconceptional vitamin A use: how much is teratogenic?
@ast
Periconceptional vitamin A use: how much is teratogenic?
@en
Periconceptional vitamin A use: how much is teratogenic?
@nl
type
label
Periconceptional vitamin A use: how much is teratogenic?
@ast
Periconceptional vitamin A use: how much is teratogenic?
@en
Periconceptional vitamin A use: how much is teratogenic?
@nl
prefLabel
Periconceptional vitamin A use: how much is teratogenic?
@ast
Periconceptional vitamin A use: how much is teratogenic?
@en
Periconceptional vitamin A use: how much is teratogenic?
@nl
P2093
P1476
Periconceptional vitamin A use: how much is teratogenic?
@en
P2093
A G Hendrickx
R K Miller
U W Wiegand
P356
10.1016/S0890-6238(97)00102-0
P577
1998-01-01T00:00:00Z